Shuttle Pharmaceuticals (SHPH) Competitors $0.13 -0.01 (-9.35%) Closing price 04:00 PM EasternExtended Trading$0.13 0.00 (-1.36%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. APLM, GTBP, MYNZ, SBFM, CHRO, OMGA, IMCC, KTTA, ALBT, and AIMShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Apollomics (APLM), GT Biopharma (GTBP), Mainz Biomed (MYNZ), Sunshine Biopharma (SBFM), Chromocell Therapeutics (CHRO), Omega Therapeutics (OMGA), IM Cannabis (IMCC), Pasithea Therapeutics (KTTA), Avalon GloboCare (ALBT), and AIM ImmunoTech (AIM). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors Apollomics GT Biopharma Mainz Biomed Sunshine Biopharma Chromocell Therapeutics Omega Therapeutics IM Cannabis Pasithea Therapeutics Avalon GloboCare AIM ImmunoTech Shuttle Pharmaceuticals (NASDAQ:SHPH) and Apollomics (NASDAQ:APLM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation. Which has better valuation & earnings, SHPH or APLM? Shuttle Pharmaceuticals has higher earnings, but lower revenue than Apollomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.03Apollomics$1.22M5.82-$172.60MN/AN/A Does the media prefer SHPH or APLM? In the previous week, Shuttle Pharmaceuticals had 6 more articles in the media than Apollomics. MarketBeat recorded 7 mentions for Shuttle Pharmaceuticals and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Shuttle Pharmaceuticals' score of 0.48 indicating that Apollomics is being referred to more favorably in the news media. Company Overall Sentiment Shuttle Pharmaceuticals Neutral Apollomics Very Positive Is SHPH or APLM more profitable? Apollomics' return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -583.02% -258.92% Apollomics N/A N/A N/A Does the MarketBeat Community prefer SHPH or APLM? Apollomics received 4 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformShuttle PharmaceuticalsN/AN/AApollomicsOutperform Votes480.00% Underperform Votes120.00% Do institutionals & insiders hold more shares of SHPH or APLM? 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 19.1% of Apollomics shares are owned by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, SHPH or APLM? Shuttle Pharmaceuticals has a beta of -1.1, suggesting that its stock price is 210% less volatile than the S&P 500. Comparatively, Apollomics has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. SummaryApollomics beats Shuttle Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.46M$6.85B$5.56B$8.50BDividend YieldN/A2.53%5.28%4.16%P/E Ratio-0.038.4326.6419.64Price / SalesN/A262.52407.99152.17Price / CashN/A65.8538.2534.64Price / Book0.076.536.974.60Net Income-$6.59M$143.25M$3.23B$248.06M7 Day Performance-27.59%0.21%-0.98%-1.03%1 Month Performance-36.18%10.92%7.70%3.50%1 Year PerformanceN/A2.44%31.32%12.68% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.8016 of 5 stars$0.13-9.4%N/AN/A$1.46MN/A-0.035News CoverageStock SplitShort Interest ↓High Trading VolumeAPLMApollomics1.2414 of 5 stars$6.55flatN/A-68.7%$7.23M$1.22M0.0045Gap DownGTBPGT Biopharma2.6733 of 5 stars$2.79+3.0%$11.00+294.3%-5.4%$7.22MN/A-0.498Positive NewsShort Interest ↑Gap UpMYNZMainz Biomed2.7735 of 5 stars$2.05+0.2%$14.00+584.6%-92.5%$7.02M$893.99K-0.0330Positive NewsGap DownSBFMSunshine Biopharma2.8579 of 5 stars$1.52+7.2%$15.00+885.5%+457.5%$6.95M$36.23M-0.013CHROChromocell Therapeutics1.1778 of 5 stars$1.05+2.9%N/A+3.9%$6.93MN/A-0.854Short Interest ↓Gap UpOMGAOmega Therapeutics1.9676 of 5 stars$0.13-21.8%$9.20+7,260.0%-94.1%$6.92M$8.10M-0.09120Upcoming EarningsGap UpIMCCIM Cannabis0.4083 of 5 stars$3.05-12.4%N/A-8.4%$6.81M$54.47M-0.89340Short Interest ↑Gap DownHigh Trading VolumeKTTAPasithea Therapeutics1.5848 of 5 stars$0.91-2.5%N/A-85.7%$6.75MN/A-0.093Short Interest ↓Gap DownALBTAvalon GloboCare2.2102 of 5 stars$3.55-2.5%N/A-59.0%$6.72M$1.37M-0.185Short Interest ↓AIMAIM ImmunoTech2.0323 of 5 stars$0.09-22.3%$2.75+2,908.8%-76.1%$6.61M$170K-0.1920News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies APLM Alternatives GTBP Alternatives MYNZ Alternatives SBFM Alternatives CHRO Alternatives OMGA Alternatives IMCC Alternatives KTTA Alternatives ALBT Alternatives AIM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SHPH Stock Free SHPH Stock Alerts